« Former New Orleans safety Steve Gleason raises ALS awareness at Super Bowl – newjerseynewsroom.com | Home | Adeona Appoints C. Evan Ballantyne as Chief Financial Officer – MarketWatch (press release) »
Low-dose MNC hUCB therapy effective in ALS-modeled mice – News-Medical.net
By | February 7, 2012
|
Low-dose MNC hUCB therapy effective in ALS-modeled mice
News-Medical.net Although previous studies found single high doses of MNC hUBC administered to pre-symptomatic ALS-modeled mice effective, the USF researchers considered a single high dose for clinical purposes "impractical." "Our present pre-clinical, … and more » |
Topics: Uncategorized | No Comments »